Guardian Therapeutics
PrivateCompany Overview
Guardian Therapeutics operates in Healthcare & Life Sciences and is based in Lowell, Massachusetts. It was founded in 2018.
Guardian Therapeutics is a biotechnology company that discovers and develops aptamer-based therapeutics for hematology, oncology, dermatology, and gastroenterology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guardian Therapeutics Comparables
Compare Guardian Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PentaBind | 82% | |
| TAGCyx Biotechnologies Inc. | 80% | |
| Aptagen, LLC | 78% |
For institutional investors. Book with your work email.
Guardian Therapeutics Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors grew 32% MoM to 674.
For institutional investors. Book with your work email.
Guardian Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Guardian Therapeutics's valuation, stock price, and market status.
Is Guardian Therapeutics a public or private company?
Guardian Therapeutics is a private company.
What is the current stock price of Guardian Therapeutics?
Guardian Therapeutics is a private company, so its shares have no public market price. Caplight tracks Guardian Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Guardian Therapeutics worth (valuation)?
Valuation information for Guardian Therapeutics is not publicly available.
Can I buy Guardian Therapeutics stock?
Guardian Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Guardian Therapeutics's last funding round?
Funding round information for Guardian Therapeutics is not publicly available.
Who are the main investors in Guardian Therapeutics?
Investor information for Guardian Therapeutics is not publicly disclosed.
Will Guardian Therapeutics IPO soon?
No public IPO plans have been announced for Guardian Therapeutics.
How can I track Guardian Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Guardian Therapeutics's shares on secondary markets.